Pricing Log in Create free account
Saturday 17 October 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

STERIS plc (STE) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, STERIS plc (STE) trades at a P/B ratio of 3.0×. Over the past ten years it has ranged from 1.5× (June 2016) to 7.4× (December 2019); the current reading is higher than 31% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 3.0× (10.68%)
FY2025 3.4× (2.31%)
FY2024 3.5× 10.37%
FY2023 3.1× (13.04%)
FY2022 3.6× (13.61%)
FY2021 4.2× 20.14%
FY2020 3.5× 2.62%
FY2019 3.4× 40.64%
FY2018 2.4× 13.85%
FY2017 2.1× 27.82%

Quarterly newest first

Period P/B ratio Change
Jun 2026 2.8× (5.67%)
Mar 2026 3.0× (13.13%)
Dec 2025 3.5× 0.17%
Sep 2025 3.5× 2.24%
42 more quarters

Against its own ten years

Low 1.5× High 7.4×
Ten-year median 3.4×
Current reading's percentile 33

P/B ratio against peers

Company P/B ratio
BIO.B Bio-Rad Laboratories, Inc. compare 1.4×
ZBH Zimmer Biomet Holdings, Inc. compare 1.4×
PHG Koninklijke Philips N.V. compare 1.8×
GMED Globus Medical, Inc. compare 2.2×
SNN Smith & Nephew SNATS, Inc. compare 2.5×
GEHC GE HealthCare Technologies Inc. compare 2.9×
STE STERIS plc 3.0×
PEN Penumbra, Inc. compare 8.2×
DXCM DexCom, Inc. compare 12.5×
Medical Devices industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on STE